# FDA Inspection 1182310 - International Tissue Inc - October 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/international-tissue-inc/ae51fdf2-e39d-4231-8df0-bfd9ebd68486
Source feed: FDA_Inspections

> FDA Inspection 1182310 for International Tissue Inc on October 20, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182310
- Company Name: International Tissue Inc
- Inspection Date: 2022-10-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1182310 - 2022-10-20](https://www.keypedia.com/records/fda_inspections/international-tissue-inc/2a71aeff-a21f-4377-971c-c726d8974db6)
- [FDA Inspection 1182310 - 2022-10-20](https://www.keypedia.com/records/fda_inspections/international-tissue-inc/892d89fc-169e-4301-8a93-3e9426a97065)

Company: https://www.keypedia.com/companies/international-tissue-inc/eb2d0597-f44c-491e-a3ac-ac0103486e74

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d